Stats show the HPV vaccine has reduced cervical cancer rates by 87 per cent. 

The rate of cervical cancer in the UK has dropped 87 per cent in the generation of women offered the human papapillomavirus (HPV) vaccine as a teen compared to previous generations, according to international research. 

The vaccine protects against the two most common HPV types, responsible for about 70 to 80 per cent of cervical cancers. 

Looking at cancer registry data, the researchers compared cervical cancer rates in cohorts of women vaccinated at different ages with similar unvaccinated cohorts. 

The researchers say rates dropped by 87 per cent among those offered the vaccine at 12-13 years old, with a 62 per cent reduction in the cohort offered the vaccine at 14-16 years old and 34 per cent for those eligible at 16-18 years old, a cohort with lower vaccine take-up.

The full study is accessible here.